Iovance Biotherapeutics Inc
IOVA
Market Cap$1.9B
Close$
$0.20
96.7% downside
Current Fair Value
96.7% downsideOvervalued by 96.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.90 Billion |
|---|---|
| Enterprise Value | $1.82 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.89 |
| Beta | 0.59 |
| Outstanding Shares | 303,269,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.62 |
|---|---|
| PEG | 17.4 |
| Price to Sales | - |
| Price to Book Ratio | 3.13 |
| Enterprise Value to Revenue | 20.02 |
| Enterprise Value to EBIT | -4.23 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Iovance Biotherapeutics Inc
CEO: Maria Fardis